239 related articles for article (PubMed ID: 33343836)
1. Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo.
Leblanc R; Kashyap R; Barral K; Egea-Jimenez AL; Kovalskyy D; Feracci M; Garcia M; Derviaux C; Betzi S; Ghossoub R; Platonov M; Roche P; Morelli X; Hoffer L; Zimmermann P
J Extracell Vesicles; 2020 Dec; 10(2):e12039. PubMed ID: 33343836
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
[TBL] [Abstract][Full Text] [Related]
3. Heparanase activates the syndecan-syntenin-ALIX exosome pathway.
Roucourt B; Meeussen S; Bao J; Zimmermann P; David G
Cell Res; 2015 Apr; 25(4):412-28. PubMed ID: 25732677
[TBL] [Abstract][Full Text] [Related]
4. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
Lee KM; Seo EC; Lee JH; Kim HJ; Hwangbo C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298370
[TBL] [Abstract][Full Text] [Related]
5. Heparanase Involvement in Exosome Formation.
David G; Zimmermann P
Adv Exp Med Biol; 2020; 1221():285-307. PubMed ID: 32274714
[TBL] [Abstract][Full Text] [Related]
6. Syntenin and syndecan in the biogenesis of exosomes.
Friand V; David G; Zimmermann P
Biol Cell; 2015 Oct; 107(10):331-41. PubMed ID: 26032692
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.
Baietti MF; Zhang Z; Mortier E; Melchior A; Degeest G; Geeraerts A; Ivarsson Y; Depoortere F; Coomans C; Vermeiren E; Zimmermann P; David G
Nat Cell Biol; 2012 Jun; 14(7):677-85. PubMed ID: 22660413
[TBL] [Abstract][Full Text] [Related]
8. Syntenin mediates SRC function in exosomal cell-to-cell communication.
Imjeti NS; Menck K; Egea-Jimenez AL; Lecointre C; Lembo F; Bouguenina H; Badache A; Ghossoub R; David G; Roche S; Zimmermann P
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12495-12500. PubMed ID: 29109268
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin-6 negatively regulates exosome production.
Ghossoub R; Chéry M; Audebert S; Leblanc R; Egea-Jimenez AL; Lembo F; Mammar S; Le Dez F; Camoin L; Borg JP; Rubinstein E; David G; Zimmermann P
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5913-5922. PubMed ID: 32108028
[TBL] [Abstract][Full Text] [Related]
10. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
Grootjans JJ; Reekmans G; Ceulemans H; David G
J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
[TBL] [Abstract][Full Text] [Related]
11. Syntenin-knock out reduces exosome turnover and viral transduction.
Kashyap R; Balzano M; Lechat B; Lambaerts K; Egea-Jimenez AL; Lembo F; Fares J; Meeussen S; Kügler S; Roebroek A; David G; Zimmermann P
Sci Rep; 2021 Feb; 11(1):4083. PubMed ID: 33602969
[TBL] [Abstract][Full Text] [Related]
12. Syntenin: Key player in cancer exosome biogenesis and uptake?
Fares J; Kashyap R; Zimmermann P
Cell Adh Migr; 2017 Mar; 11(2):124-126. PubMed ID: 27589080
[TBL] [Abstract][Full Text] [Related]
13. Heparanase tailors syndecan for exosome production.
David G; Zimmermann P
Mol Cell Oncol; 2016 May; 3(3):e1047556. PubMed ID: 27314072
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" Approach.
Hoffer L; Garcia M; Leblanc R; Feracci M; Betzi S; Ben Yaala K; Daulat AM; Zimmermann P; Roche P; Barral K; Morelli X
J Med Chem; 2023 Apr; 66(7):4633-4658. PubMed ID: 36939673
[TBL] [Abstract][Full Text] [Related]
16. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
Zimmermann P; Tomatis D; Rosas M; Grootjans J; Leenaerts I; Degeest G; Reekmans G; Coomans C; David G
Mol Biol Cell; 2001 Feb; 12(2):339-50. PubMed ID: 11179419
[TBL] [Abstract][Full Text] [Related]
17. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
[TBL] [Abstract][Full Text] [Related]
18. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
Shimada T; Yasuda S; Sugiura H; Yamagata K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-regulated phase separation of syndecan-4 and syntenin promotes the biogenesis of exosomes.
Zhao T; Yang X; Duan G; Chen J; He K; Chen YX; Luo SZ
Cell Prolif; 2024 Apr; ():e13645. PubMed ID: 38601993
[TBL] [Abstract][Full Text] [Related]
20. Syntenin-targeted peptide blocker inhibits progression of cancer cells.
Liu J; Qu J; Zhou W; Huang Y; Jia L; Huang X; Qian Z; Xia J; Yu Y
Eur J Med Chem; 2018 Jun; 154():354-366. PubMed ID: 29857221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
